Lack of genomic heterogeneity at high-resolution aCGH between primary breast cancers and their paired lymph node metastases

scientific article

Lack of genomic heterogeneity at high-resolution aCGH between primary breast cancers and their paired lymph node metastases is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode2014PLoSO...9j3177V
P356DOI10.1371/JOURNAL.PONE.0103177
P8608Fatcat IDrelease_fbl6rodppfcxth5w5bfgjz5k4u
P932PMC publication ID4118860
P698PubMed publication ID25083859
P5875ResearchGate publication ID264435367

P50authorBauke YlstraQ30429855
Christiaan KlijnQ41050637
Jos JonkersQ88723772
Lodewyk F A WesselsQ89966632
P2093author name stringJelle Wesseling
Sabine C Linn
Philip C Schouten
Danielle Israeli
Marieke A Vollebergh
P2860cites workThe Hallmarks of CancerQ221226
Hallmarks of Cancer: The Next GenerationQ22252312
Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancersQ24649562
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsQ27860709
Molecular portraits of human breast tumoursQ28032461
Tumour evolution inferred by single-cell sequencingQ28646966
Inferring tumor progression from genomic heterogeneityQ28749457
Breast cancer metastasis: markers and modelsQ29618061
BRCA1-mutated and basal-like breast cancers have similar aCGH profiles and a high incidence of protein truncating TP53 mutationsQ30497664
Identification of cancer genes using a statistical framework for multiexperiment analysis of nondiscretized array CGH dataQ31142505
A multiplex PCR predictor for aCGH success of FFPE samplesQ33228753
Cross-species comparison of aCGH data from mouse and human BRCA1- and BRCA2-mutated breast cancersQ33671467
KC-SMARTR: An R package for detection of statistically significant aberrations in multi-experiment aCGH data.Q33744507
Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer.Q34422099
Intratumor genomic heterogeneity in breast cancer with clonal divergence between primary carcinomas and lymph node metastasesQ34556958
Gene expression profiles of primary breast tumors maintained in distant metastasesQ34793058
An aCGH classifier derived from BRCA1-mutated breast cancer and benefit of high-dose platinum-based chemotherapy in HER2-negative breast cancer patientsQ35064705
Basal-like breast cancer and the BRCA1 phenotypeQ36602561
Genomic profiling of breast tumours in relation to BRCA abnormalities and phenotypesQ37360179
Genetic and epigenetic alterations in sentinel lymph nodes metastatic lesions compared to their corresponding primary breast tumorsQ39664818
Identification of metastasis-associated breast cancer genes using a high-resolution whole genome profiling approachQ39672356
Across array comparative genomic hybridization: a strategy to reduce reference channel hybridizationsQ39956271
High-dose chemotherapy with hematopoietic stem-cell rescue for high-risk breast cancer.Q42163493
Distinct genomic aberration patterns are found in familial breast cancer associated with different immunohistochemical subtypesQ42522379
Does analysis of biomarkers in tumor cells in lymph node metastases give additional prognostic information in primary breast cancer?Q43137879
To DNA or not to DNA? That is the question, when it comes to molecular subtyping for the clinic!Q44207301
Genomic alterations in primary breast cancers compared with their sentinel and more distal lymph node metastases: an aCGH studyQ44517294
Patterns and incidence of chromosomal instability and their prognostic relevance in breast cancer subtypes.Q45267349
Genetic alterations in primary breast cancers and their metastases: direct comparison using modified comparative genomic hybridizationQ46564449
BRCA1 RING function is essential for tumor suppression but dispensable for therapy resistance.Q50506046
Platform comparisons for identification of breast cancers with a BRCA-like copy number profileQ50997123
Indicators of homologous recombination deficiency in breast cancer and association with response to neoadjuvant chemotherapyQ54644370
Chromosomal genotype in breast cancer progression: comparison of primary and secondary manifestations.Q55122387
Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancerQ69926364
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue8
P407language of work or nameEnglishQ1860
P304page(s)e103177
P577publication date2014-08-01
P1433published inPLOS OneQ564954
P1476titleLack of genomic heterogeneity at high-resolution aCGH between primary breast cancers and their paired lymph node metastases
P478volume9

Reverse relations

cites work (P2860)
Q47184894Array comparative genomic hybridization of 18 pancreatic ductal adenocarcinomas and their autologous metastases
Q36271396Clinical implications of molecular heterogeneity in triple negative breast cancer.
Q37317214Comparative genomic analysis of primary tumors and metastases in breast cancer.
Q28274373Cross-Clustering: A Partial Clustering Algorithm with Automatic Estimation of the Number of Clusters
Q37379842FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancer
Q53118366Gene promoter hypermethylation is found in sentinel lymph nodes of breast cancer patients, in samples identified as positive by one-step nucleic acid amplification of cytokeratin 19 mRNA.
Q41136538Robust BRCA1-like classification of copy number profiles of samples repeated across different datasets and platforms

Search more.